Fabry disease (FD) is an X-linked lysosomal storage disease characterised by glycosphingolipid globotriaosylceramide (Gb3) accumulation in the lysosomes of multiple organs including the kidneys.
Anecdotally we observed a higher-than-expected incidence of renal cell carcinoma (RCC) in FD patients.
